Our results demonstrate that in an increased diabetic environment (PreDM, T2D), the associations between PCSK9 and lipid classes significantly change, yet the potency of statin medication was not diminished in the diabetic subjects. Here, PCSK9 is linked to type 2 diabetes mellitus.